The Cardiovascular Impact of COVID-19

The novel coronavirus disease (COVID-19) outbreak, caused by SARS-CoV-2, represents the greatest medical challenge in decades. While COVID-19 primarily affects the lungs, causing interstitial pneumonitis and severe acute respiratory distress syndrome (ARDS), it also affects multiple organs, particularly the cardiovascular system. Risk of severe infection and mortality increase with advancing age and male sex. Mortality is increased by comorbidities: cardiovascular disease, hypertension, diabetes, chronic pulmonary disease, and cancer. The most common complications include arrhythmia , cardiac injury, fulminant myocarditis, heart failure, pulmonary embolism, and disseminated intravascular coagulation (DIC).

 

 

  • Cardiac stress test
  • Cardiac ventriculography
  • Positron emission photography
  • Tilt table test
  • Radionucleide angiography
  • Phonocardiogram
  • Computed tomography angiography

Related Conference of The Cardiovascular Impact of COVID-19

January 25-26, 2024

39th World Cardiology Conference

London, UK
February 08-09, 2024

3rd International Conference on Cardiology

Paris, France
March 07-08, 2024

38th World Congress on Heart Diseases

Toronto, Canada
March 11-12, 2024

13th World Heart Congress

Paris, France
May 30-31, 2024

6th Euro Cardiology Congress

Vienna, Austria
May 30-31, 2024

39th World Congress on Heart Diseases

Vienna, Austria
June 20-21, 2024

5th European Summit on Cardiology Research

Dublin, Ireland
July 16-17, 2024

13th World Heart Congress

Paris, France

The Cardiovascular Impact of COVID-19 Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in